Engineered Gut Bacteria Therapy Emerges as Scalable Potential Alternative to Fecal Microbiota Transplants Following Clinical Trial
New York, June 2: Researchers at the Icahn School of Medicine at Mount Sinai have developed a new manufacturing platform…
